A 26-year-old is now "cancer-free" after receiving a new treatment for colorectal cancer. "I was declared cancer free in July of 2025, and I've taken three trips since then," Mrinali Dhembla, 26, told "Good Morning America" in an interview that aired Monday.

CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret value.

First-line treatment for advanced urothelial carcinoma has evolved in recent years from traditional chemotherapy to targeted immunotherapy drugs enfortumab vedotin (Padcev) and pembrolizumab (Keytruda).

Nearly 10,000 cases of advanced bowel cancer are diagnosed in England each year, with cases in young adults rising. There are limited options for treating advanced bowel cancer. Scientists have now developed an AI-powered method that could determine which patients with advanced bowel cancer are most likely to respond to a targeted drug used on the NHS—potentially sparing thousands of patients from treatments that won't work for them.

Merck built a wall of patents to keep a cancer drug's price – and its profits – high. Hospitals often add to the cost for American patients.

Shares of Revolution Medicines rose after the company said a late-stage trial of its treatment for certain pancreatic cancer patients demonstrated statistically significant and clinically meaningful improvements in progression-free and overall survival,

Dr. Sandy Srinivas explains how age, comorbidities and medications influence personalized prostate cancer treatment decisions. At the 2026 NCCN Annual Meeting, CURE sat down on site with Sandy Srinivas,

“People should not have to beg to get help,” said Eric Tennant’s widow Becky